Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jacob Koruth

Clinical Cardiac Electrophysiology New York, NY Medical Doctor

NPI 1265652051 CMS profile 57672

1190 5Th Ave, Ste 1030, New York, NY 10029

Open in the dashboard

General payments

$3,654,414

732 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$299,527 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jacob Koruth of New York, NY is reported in the CMS Open Payments database as having received $3,654,414 across 732 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $299,527 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $460,179 266
2024 General $493,403 210
2023 General $538,315 108
2022 General $1,942,788 60
2021 General $152,955 20
2020 General $6,955 17
2019 General $59,817 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacob Koruth
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Jacob Koruth were reported at $460,179. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Jacob Koruth Clinical Cardiac Electrophysiology median Middle half National median
2019 $59,817 $2,361 $585–$8,260 $163
2020 $6,955 $993 $247–$4,351 $114
2021 $152,955 $1,185 $326–$4,739 $132
2022 $1,942,788 $2,073 $554–$6,789 $149
2023 $538,315 $2,568 $759–$8,159 $160
2024 $493,403 $2,557 $703–$7,403 $164
2025 $460,179 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $2,582,670 252 payments
  2. Boston Scientific Corporation $447,567 213 payments
  3. Abbott Laboratories $230,741 167 payments
  4. Pulse Biosciences, Inc. $207,189 19 payments
  5. Biosense Webster, Inc. $81,605 34 payments
  6. Acutus Medical, Inc. $47,494 8 payments
  7. CardioFocus, Inc. $35,299 6 payments
  8. Abiomed $10,113 10 payments
  9. Philips Electronics North America Corporation $5,400 1 payment
  10. Medical Device Business Services, Inc. $3,366 1 payment
  11. Other $2,970 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $2,696,537 12 payments
  2. Consulting Fee $556,991 87 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $227,541 61 payments
  4. Travel and Lodging $129,030 298 payments
  5. Food and Beverage $17,856 262 payments
  6. Honoraria $10,950 3 payments
  7. Grant $6,372 2 payments
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $5,100 3 payments
  9. Compensation for serving as faculty or as a speaker for a medical education program $4,038 4 payments
Products named General payments · program years 2019–2025
  1. CellFx $207,189 19 payments
  2. GENERAL EP $109,364 2 payments
  3. Carto 3 $51,305 18 payments
  4. ENSITE Electrophysiology $50,199 12 payments
  5. FARAPULSE Farapulse_Rm $48,728 23 payments
  6. GENERAL - EP $39,626 3 payments
  7. FLEXABILITY $37,816 13 payments
  8. FARAPULSE Farapulse_Ep $32,938 41 payments
  9. TACTICATH ABLATION CATHETER, SENSOR ENABLED $32,878 16 payments
  10. ENSITE Structural Heart $32,216 17 payments
  11. Other $150,479 294 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

152

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$53,066

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

28.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 44 $44,808
Dofetilide Generic 38 $7,504
Flecainide Acetate Generic 26 $381
Metoprolol Succinate Generic 33 $314
Amiodarone Hcl Generic 11 $59

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$201,978

Medicare's payments for the services billed

Medicare patients

2,011

Average age 77

Services billed

4,213

896 women, 1,115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 61%
Atrial fibrillation 57%
Arthritis 53%
Heart failure 50%
Diabetes 46%
Chronic kidney disease 38%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

732 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record